Amebicides

"Amebicides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal.


expand / collapse Publications
This graph shows the total number of publications written about "Amebicides" by people in this website by year, and whether "Amebicides" was a major or minor topic of these publications.
Below are the most recent publications written about "Amebicides" by people in Profiles.
  1. High-Throughput Screen of Microbial Metabolites Identifies F1FO ATP Synthase Inhibitors as New Leads for Naegleria fowleri Infection. ACS Infect Dis. 2023 12 08; 9(12):2622-2631.
    View in: PubMed
  2. Development of a Machine Learning-Based Cysticidal Assay and Identification of an Amebicidal and Cysticidal Marine Microbial Metabolite against Acanthamoeba. Microbiol Spectr. 2022 06 29; 10(3):e0007722.
    View in: PubMed
  3. Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs. Expert Rev Anti Infect Ther. 2021 11; 19(11):1427-1441.
    View in: PubMed
  4. The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii. Antimicrob Agents Chemother. 2020 04 21; 64(5).
    View in: PubMed
  5. Identification of Four Amoebicidal Nontoxic Compounds by a Molecular Docking Screen of Naegleria fowleri Sterol Δ8-Δ7-Isomerase and Phenotypic Assays. ACS Infect Dis. 2019 12 13; 5(12):2029-2038.
    View in: PubMed
  6. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole. Cornea. 2019 Oct; 38(10):1309-1313.
    View in: PubMed
  7. Editorial: Recent Progresses in Amebiasis. Front Cell Infect Microbiol. 2019; 9:247.
    View in: PubMed
  8. Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen Balamuthia mandrillaris. mBio. 2018 10 30; 9(5).
    View in: PubMed
  9. CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM). PLoS Negl Trop Dis. 2017 12; 11(12):e0006104.
    View in: PubMed
  10. Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature. Transpl Infect Dis. 2017 Apr; 19(2).
    View in: PubMed